Patent · US Active

Bodily substance detection by evaluating photoluminescent response to excitation radiation

US12295655B2 · kind B2 · utility

0Cited by
10References
14Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMay 15, 2023
Grant dateMay 13, 2025
Priority date
Expiry dateMay 15, 2043

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61B2018/00904
  • WIPO fieldMedical technology
  • WIPO sectorInstruments

Abstract

A medical device may include an ablation device configured to deliver ablation energy to a treatment site. The medical device may further include a probe device configured to deliver excitation radiation to the treatment site. Further the medical device may include a radiation-receiving device configured to receive photoluminescence radiation emitted from the treatment site in response to the treatment site being illuminated by the excitation radiation and to generate a detection signal in response to the received photoluminescence radiation. Additionally, the excitation radiation may be different from the ablation energy.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.